Moderna and Retail Investors
December 02, 2020 at 04:44 AM EST
Shares of Moderna spiked 20% Monday on news it had requested FDA clearance for its COVID-19 vaccine. Both Bloomberg’s Joe Wiesenthal and Julianna Tatelbaum wondered why though.
